India) and anti β-Actin antibody was purchased from Abcam (Cambridge, MA, USA). HRP conjugated goat anti-rabbit and goat anti mouse secondary antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Cy-3 conjugated anti-rabbit secondary antibody was purchased from Jackson Laboratories (West grove, PA, USA).
Particle size distribution and zeta potential
The hydrodynamic sizes of liposomal formulations were analyzed by dynamic light scattering (DLS) performed on a DynaPro Nano DLS system (Wyatt Technologies, Santa Barbara, CA, USA). A Zetasizer (Malvern, UK) was used to determine the zeta potential of the siRNA encapsulated liposomes. All measurements were performed at a fixed angle of 90 0 at room temperature (25°C). The results were expressed as the size ± standard deviation and zeta potential ± standard deviation.
siRNA entrapment and Gel retardation assay
1 µg of scrambled siRNA in was entrapped inside the liposomes by freeze thaw method. On the other hand was liposomes incubated with 1 µg siRNA scrambled siRNA at room temperature for 20 minutes before loading onto the gel. Above mentioned samples and the equivalent amount of naked siRNA was separately loaded on to the gel. The electrophoretic mobility of twas visualized using an ultraviolet illuminator with ethidium bromide staining after electrophoresis on 2% (w/v) agarose gel for 20 minutes at 80 V in TAE buffer (40 mM Tris-HCl, 1% v/v acetic acid, 1 mM EDTA).
RNase protection assay
To prevent digestion of siRNA by endonucleases, we performed a nuclease protection assay, where samples of naked siRNA and the siRNA entrapped liposomal formulations and electrostatic lipoplexes were treated with RNase-A for 30 minutes. The samples were then treated with 8 U of RNase-A inhibitor at 37°C for 15 minutes and run on 2% agarose gel for 20 minutes at 80 V in TAE buffer (40 mM Tris-HCl, 1% v/v acetic acid, 1 mM EDTA). The gel was visualized under an ultraviolet illuminator after staining with ethidium bromide.
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Morphology
The morphological examination of empty Liposomes, lipo-PTX, lipo-siRNA and lipo-PTX/ siRNA was performed using SEM, Hitachi S-3400N Tokyo, Japan. Liquid sample was placed on a coverslip, dried and coated with gold before observing and analyzing under scanning electron microscopy.
Cellular uptake by flow cytometric analysis
The B16F10 and NIH/3T3 cells were seeded at a density of 2 x 10 5 cells/6-well plate and allowed to adhere for 24 h. The cells were exposed to lipo-PTX/FITC-siRNA and incubated for 4 h. The cells were washed twice with PBS, trypsinized, collected and re-suspended in PBS. The amount of cellular uptake was confirmed by flow cytometry (Becton Dickinson, Sunnyvale, CA).
Confocal microscopy
Confocal Laser Scanning microscopic (CSLM) analysis was carried out to observe the uptake of liposomes within the cells. B16F10 and NIH/3T3 cells were grown on coverslips for 24 h, followed by transfection with FITC-labelled siRNA entrapped liposomal nanparticles for 4 h.
The cells were washed with PBS buffer and fixed with 4% paraformaldehyde (PFA) for 20 min. The cells were then mounted with vectashield mounting media (Vector Laboratories, Inc, Burlingame, CA, USA) and observed under FV1000 confocal laser scanning microscope (FV1000, Olympus, Japan).
Cell cycle analysis by flow cytometry
B16F10 cells were seeded at a density of 2 x 10 5 cells/6 well plate and allowed to adhere for 24 h. Thereafter the cells were treated with liposomes and incubated for 24 h at 37 °C in a standard incubator. The cells were trypsinized, harvested, and centrifuged using a microcentrifuge at 1500 rpm for 4 min. The cell pellets were washed twice with PBS buffer and fixed in 75% ethanol solution at 4 °C followed by brief centrifugation, and washed with PBS. They were again resuspended in PBS containing 5 mg/mL PI and 50 mg/mL deoxyribonuclease-free ribonuclease A. The suspension was incubated in dark for 25 min and analysed for cell cycle patterns using flow cytometry.
RT-PCR analysis
Total RNA was extracted using RNeasy mini kit (Qiagen, Valencia, CA, USA) and reverse transcribed into cDNA using superscript II reverse transcriptase (Invitrogen, Carlsbad, CA.
USA). PCR was carried out with specific primers for GAPDH, Bcl-2 (Table S1) in Eppendorf thermal cycler. The products were electrophoresed on agarose gel (1%) containing ethidium bromide and visualized under U V light. The signal intensity of respective bands was measured by means of the Quantity One version 4.1.1 software using BIORAD image analysis system (Hercules, CA, USA).
Western blot analysis:
To assay changes in apoptotic protein levels, after co-delivery with liposomes in B16F10 cells, both treated and untreated cells were collected and lysed in RIPA lysis buffer (SigmaAldrich, St. Louis, MO, USA) . Cell lysate was collected by centrifugation.
To observe the expression of apoptotic proteins both before and after co-delivery of liposomal samples in tumor, 1mg of tumor tissue was collected, washed with PBS and homogenised in RIPA lysis buffer. Protein lysate was collected by centrifugation.
In both in vitro and in vivo experimental condition, total protein concentration was Synthetic methods and Spectral data of prepared compounds:
Supplementary Tables
1-hexadecyl-1H-imidazole (Compound-2)
1-bromohexadecane (3.2mmol) was added drop wise to a stirred solution of imidazole (3.2mmol) and NaH (3.41mmol) in THF (20mL) at 0 0 C. Reaction mixture was maintained at ambient temperature for 30 min. After completion of reaction, quenched with water and extracted with ethyl acetate (2x50) and dried over sodium sulphate.
N N 15
Solid, m. 9, 128.8, 118.7, 47.1, 31.8, 31.0, 29.6, 29.5, 29.4, 29.3, 29.0, 26.4, 22.6, 14.0 
5-(hexadecyloxy)-2-(hydroxymethyl)-4H-pyran-4-one (Compound-4)
Kojic acid (7.04mmol) was dissolved in dry DMF and added K 2 CO 3 (8.8mmol,) after 30 mins 1-bromohexadecane was added dropwise to the above solution. Heated the reaction mixture overnight and extracted the organic solvent with ethyl acetate and dried over sodium sulphate and purified by column chromatography. 7, 166.8, 147.8, 139.0, 111.8, 69.7, 60.9, 31.9, 29.6, 29.5, 29.3, 28.9, 25.7, 22.6,14 .1 ppm ; IR (KBr): ν max 3454, 3196, 3079, 2915, 2848, 1649, 1617, 1468, 1364, 1275, 1219, 1152, 1068, 1017, 994, 944, 870, 811, 748, 717, 543 
1-hexadecyl-3-((5-(hexadecyloxy)-4-oxo-4H-pyran-2-yl)methyl)-1H-imidazol-3-ium (Compoud-6)
CBr 4 (3.3mmol) and triphenyl phosphene (3.3mmol) was added to 5-(hexadecyloxy)-2-(hydroxymethyl)-4H-pyran-4-one (2.76mmol) dissolved in dichloromethane at 0 0 C. Reaction was maintained at ambient temperature for 1 h. Then solvent was evaporated and the crude product obtained was used without further purification.
The above prepared compound (2.3 mmol) and 1-hexadecyl-1H-pyrrole (2.3mmol) were taken in to acetonitrile and refluxed for 3 h. Reaction mixture was cooled to RT and washed with ethyl acetate for three times to obtained pure product as off white coloured solid. 157.4, 146.8, 138.4, 135.9, 122.9, 121.7, 114.1, 68.3, 48.9, 48.3, 30.6, 28.8, 28.3, 28.1, 28.0, 27.7, 24.9, 24.5, 21.4, 13.0 
